American Bio Medica Stock Forecast, Price & News

+0.00 (+2.64 %)
(As of 04/12/2021 03:24 PM ET)
Today's Range
Now: $0.11
50-Day Range
MA: $0.15
52-Week Range
Now: $0.11
Volume52,630 shs
Average Volume327,931 shs
Market Capitalization$4.49 million
P/E RatioN/A
Dividend YieldN/A
American Bio Medica Corporation develops, manufactures, and sells lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides bulk test strip contract manufacturing services to non-affiliated diagnostic companies. American Bio Medica Corporation serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets in the United States and internationally. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was founded in 1986 and is based in Kinderhook, New York.
American Bio Medica logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:ABMC
Year FoundedN/A



Sales & Book Value

Annual Sales$3.65 million
Book Value($0.02) per share


Net Income$-680,000.00


Market Cap$4.49 million
Next Earnings Date7/30/2021 (Estimated)
OptionableNot Optionable


ABMC Announces The Filing of Form 12b-25
March 31, 2021 |  finance.yahoo.com
ABMC Distributes Rapid Antigen Test For Covid-19
December 14, 2020 |  finance.yahoo.com
ABMC Uplists to the OTCQB Venture Market
December 2, 2020 |  finance.yahoo.com
ABMC Reports Third Quarter 2020 Results
November 16, 2020 |  finance.yahoo.com
ABMC Reports Second Quarter 2020 Results
September 15, 2020 |  finance.yahoo.com
ABMC Reports First Quarter 2020 Results
July 31, 2020 |  finance.yahoo.com
American Bio Medica (ABMC) Stock
July 7, 2020 |  markets.businessinsider.com
ABMC Reports Fourth Quarter and Year End 2019 Results
June 26, 2020 |  finance.yahoo.com
American Bio Medica Corporation (ABMC)
May 16, 2020 |  finance.yahoo.com
See More Headlines


Overall MarketRank

0.52 out of 5 stars

Medical Sector

1537th out of 2,016 stocks

Pharmaceutical Preparations Industry

652nd out of 771 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
+0.00 (+2.64 %)
(As of 04/12/2021 03:24 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ABMC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABMC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

American Bio Medica (OTCMKTS:ABMC) Frequently Asked Questions

What stocks does MarketBeat like better than American Bio Medica?

Wall Street analysts have given American Bio Medica a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but American Bio Medica wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting American Bio Medica?

American Bio Medica saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 29,100 shares, an increase of 5,720.0% from the February 28th total of 500 shares. Based on an average trading volume of 507,500 shares, the short-interest ratio is presently 0.1 days.
View American Bio Medica's Short Interest

When is American Bio Medica's next earnings date?

American Bio Medica is scheduled to release its next quarterly earnings announcement on Friday, July 30th 2021.
View our earnings forecast for American Bio Medica

How were American Bio Medica's earnings last quarter?

American Bio Medica Co. (OTCMKTS:ABMC) released its quarterly earnings data on Monday, May, 14th. The company reported ($0.01) earnings per share for the quarter. The business earned $1.04 million during the quarter.
View American Bio Medica's earnings history

How has American Bio Medica's stock been impacted by COVID-19?

American Bio Medica's stock was trading at $0.0628 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ABMC shares have increased by 79.8% and is now trading at $0.1129.
View which stocks have been most impacted by COVID-19

Who are American Bio Medica's key executives?

American Bio Medica's management team includes the following people:
  • Ms. Melissa A. Waterhouse, Chairman, CEO & Principal Financial Officer (Age 50, Pay $191.08k)
  • Ms. Jean Neff, Corp. Sec. & Independent Director (Age 78)
  • Mr. Edmund M. Jaskiewicz, Pres & Chairman Emeritus (Age 97)
  • Mr. J. Duncan Urquhart, Controller (Age 67)

Who are some of American Bio Medica's key competitors?

What other stocks do shareholders of American Bio Medica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other American Bio Medica investors own include OPKO Health (OPK), Canadian Western Bank (CWB), RespireRx Pharmaceuticals (RSPI), Workhorse Group (WKHS), The Bank of Nova Scotia (BNS), (CGC), (DFT) (DFT), Gilead Sciences (GILD), ServiceNow (NOW) and Square (SQ).

What is American Bio Medica's stock symbol?

American Bio Medica trades on the OTCMKTS under the ticker symbol "ABMC."

How do I buy shares of American Bio Medica?

Shares of ABMC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is American Bio Medica's stock price today?

One share of ABMC stock can currently be purchased for approximately $0.11.

How much money does American Bio Medica make?

American Bio Medica has a market capitalization of $4.49 million and generates $3.65 million in revenue each year.

How many employees does American Bio Medica have?

American Bio Medica employs 42 workers across the globe.

What is American Bio Medica's official website?

The official website for American Bio Medica is www.abmc.com.

Where are American Bio Medica's headquarters?

American Bio Medica is headquartered at 122 SMITH ROAD, KINDERHOOK NY, 12106.

How can I contact American Bio Medica?

American Bio Medica's mailing address is 122 SMITH ROAD, KINDERHOOK NY, 12106. The company can be reached via phone at 518-758-8158 or via email at [email protected]

This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.